SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-097599
Filing Date
2020-08-21
Accepted
2020-08-21 16:17:15
Documents
1
Period of Report
2020-08-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3614
  Complete submission text file 0001104659-20-097599.txt   5119
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CONTRAVIR PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 2012 NEW YORK NY 10170
Business Address
Block Timothy M. (Reporting) CIK: 0001593465 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36856 | Film No.: 201123587